Hutch News

Hutch News

Stories tagged 'Michael Schweizer'

‘Good cancer’? Views vary on a sunny phrase

Many patients and doctors refuse to apply the ‘g’ word to highly curable cancers, but some survivors draw hope from the ‘good’

Nov. 10, 2016 | By Bill Briggs / Fred Hutch News Service

Derided by some survivors and embraced by others, the phrase “good cancer” surged in use as cure rates rose for some malignancies, pushing that upbeat description into the fervent world of cancer language.

View story >

‘Bipolar’ therapy: Treating advanced prostate cancer with high-dose testosterone

Men with a certain type of aggressive prostate cancer may benefit from therapy that cycles hormones through high peaks and low valleys, small study finds

Jan. 7, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

A new study from researchers at Johns Hopkins Hospital and Fred Hutchinson Cancer Research Center shows that a certain type of prostate cancer, after months or years of testosterone deprivation, can develop a lethal sensitivity to testosterone in a new treatment approach – “bipolar androgen therapy” – which combines high-dose testosterone with androgen-blocking therapy.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.